Lateral flow assays: The possibilities beyond COVID-19
In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.
Source: news-medical.net